On 16 May 2018
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 May 2018, to consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2018, to consider and recommend dividend on Equity Shares, if any, for the financial year ended 31st March, 2018.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
